1. Reconciling the Clinical Practice Guidelines on Bell's Palsy from the AAO‐HNSF and the AAN
- Author
-
Gary S. Gronseth, Seth R. Schwartz, Stephanie L. Jones, and Thomas S.D. Getchius
- Subjects
medicine.medical_specialty ,Neurology ,Alternative medicine ,MEDLINE ,Antiviral Agents ,Mononeuropathy ,Otolaryngology ,Bell's palsy ,Bell Palsy ,Paralysis ,medicine ,Humans ,Evidence-Based Medicine ,Palsy ,business.industry ,Evidence-based medicine ,medicine.disease ,Facial nerve ,Clinical Practice ,stomatognathic diseases ,Otorhinolaryngology ,Practice Guidelines as Topic ,Physical therapy ,Steroids ,Surgery ,Neurology (clinical) ,medicine.symptom ,business - Abstract
Bell's palsy, named after the Scottish anatomist, Sir Charles Bell, is the most common acute mononeuropathy, or disorder affecting a single nerve, and is the most common diagnosis associated with facial nerve weakness/paralysis. In the past 2 years, both the American Academy of Neurology (AAN) and the American Academy of Otolaryngology-Head and Neck Surgery Foundation (AAO-HNSF) have published clinical practice guidelines aimed to improve the quality of care and outcomes for patients diagnosed with Bell's palsy. This commentary aims to address the similarities and differences in the scope and final recommendations made by each guideline development group.
- Published
- 2014
- Full Text
- View/download PDF